Who
Maria E. Martinez
Director
Company insider
Files Form 4 as: Director, Perspective Therapeutics; Director, Mirati Therapeutics.
In numbers
- Trades disclosed
- 32
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $1.5M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 6 Dec 2018
- Last trade
- 2 Mar 2026
- Last filed
- 4 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Mar 2026filed 4 Mar 2026 | CATX Perspective Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | CATX Perspective Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 3 Sep 2025filed 5 Sep 2025 | CATX Perspective Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 23 Jan 2024filed 23 Jan 2024 | Mirati Therapeuticsoption or derivative | SEC FORM 4 Code D | —17,500 | filing |
| 23 Jan 2024filed 23 Jan 2024 | Mirati Therapeuticsoption or derivative | SEC FORM 4 Code D | —7,520 | filing |
| 23 Jan 2024filed 23 Jan 2024 | Mirati Therapeuticsoption or derivative | SEC FORM 4 Code D | —11,000 | filing |
| 23 Jan 2024filed 23 Jan 2024 | Mirati Therapeutics | SEC FORM 4 Code D | —6,021 | filing |
| 23 Jan 2024filed 23 Jan 2024 | Mirati Therapeutics | SEC FORM 4 Code D | —4,444 | filing |
| 23 Jan 2024filed 23 Jan 2024 | Mirati Therapeutics | SEC FORM 4 Code D | —6,808 | filing |
| 29 Dec 2023filed 3 Jan 2024 | Mirati Therapeutics | SEC FORM 4 Code A | $400K6,808 at $58.75 | filing |
| 20 Jan 2023filed 24 Jan 2023 | Mirati Therapeuticsoption or derivative | SEC FORM 4 Code A | —7,520 at $0.00 | filing |
| 20 Jan 2023filed 24 Jan 2023 | Mirati Therapeutics | SEC FORM 4 Code A | —4,444 at $0.00 | filing |
| 14 Jan 2022filed 18 Jan 2022 | Mirati Therapeuticsoption or derivative | SEC FORM 4 Code A | —3,688 at $0.00 | filing |
| 14 Jan 2022filed 18 Jan 2022 | Mirati Therapeutics | SEC FORM 4 Code A | —2,546 at $0.00 | filing |
| 29 Jan 2021filed 1 Feb 2021 | Mirati Therapeuticsoption or derivative | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 29 Jan 2021filed 1 Feb 2021 | Mirati Therapeutics | SEC FORM 4 Code M | $298K7,500 at $39.76 | filing |
| 29 Jan 2021filed 1 Feb 2021 | Mirati Therapeutics | SEC FORM 4 Sold | $9,85750 at $197.14 | filing |
| 29 Jan 2021filed 1 Feb 2021 | Mirati Therapeutics | SEC FORM 4 Sold | $50K250 at $198.48 | filing |
| 29 Jan 2021filed 1 Feb 2021 | Mirati Therapeutics | SEC FORM 4 Sold | $144K719 at $200.05 | filing |
| 29 Jan 2021filed 1 Feb 2021 | Mirati Therapeutics | SEC FORM 4 Sold | $93K462 at $200.90 | filing |
News
No headline names them, or the companies they trade most, lately.